Search results for "" 2266 results found
Sort By
By Date
By Relevance
-
IP Cases & Articles
Nike v Adidas - knitted footwear war runs on
The Rio Olympics may now be a memory, but over the past few years two sportswear manufacturers have been battling it out in court, with patents being the field of play. -
IP Cases & Articles
Unjustified patent infringement threats
Unjustified threats remain an odd quirk of intellectual property law in the UK for patents, trade marks and designs. The underlying reasoning behind Section 70 Patents Act 1977 (PA '77) is to prevent what amounts to mere 'sabre-rattling' by a patent proprietor against commercial entities and end users who may… -
IP Cases & Articles
Amendments to the Patents Rules 2007
On 02 August 2016 the UK Intellectual Property Office (UKIPO) published the UK Government's response to a consultation seeking views on a number of proposed amendments to the Patents Rules 2007. -
IP Cases & Articles
Order from the Enlarged Board of Appeal in G 1/15
The EPO's Enlarged Board of Appeal has recently issued an order which apparently summarises their conclusions with respect to the issue of "poisonous divisionals". -
IP Cases & Articles
Raytheon: On-demand instantiation in a computing system
On the 22 June 2016 the Technical Board of Appeal issued its decision (T 1742/12) regarding an appeal concerning the selection of closest prior art when it is ambiguous as to which document is closest to the claimed arrangement. -
IP Cases & Articles
Patent litigation: expedited cases and numerical limits
In our October 2016 newsletter we commented on patent litigation in the UK in the light of Brexit. As we noted there, UK patent litigation proceedings have a strong reputation for quality, which will endure, and real efforts are being made to improve costs and efficiency. -
IP Cases & Articles
Undisclosed disclaimers - Enlarged Board of Appeal
New questions have been referred to the EPO Enlarged Board of Appeal regarding the allowability of disclaimers. -
IP Cases & Articles
Hospira v Genentech - Herceptin formulation obvious
In July this year, the Court of Appeal handed down a decision in Hospira v Genentech [2016] EWCA Civ 780 which upheld the decision by Birss J in November 2014 to revoke the two Herceptin formulation patents for obviousness and added matter. -
IP Cases & Articles
Warner Lambert v Actavis: Swiss form claims
The Court of Appeal has decided the latest instalment of the pregabalin second medical use litigation between Warner-Lambert (part of Pfizer) and Actavis (and other generics manufacturers) in the UK. -
IP Cases & Articles
Eligible subject-matter USPTO two-step test
Under US patent practice, laws of nature, natural phenomena and abstract ideas are not patentable.
Page 65 of 227
Previous Next